Skip to content

Video-group coping program appeared feasible in a small hepatitis C pilot

Attendance and satisfaction supported a larger trial of remote coping-skills groups, while symptom findings remained exploratory.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The pilot suggests that people with hepatitis C-related liver disease can take part in a structured coping-skills group by video, with encouraging attendance and satisfaction. Changes in some studied factors correlated with symptom improvements, but the abstract does not identify which factors. Those observations support further testing, but they do not establish symptom benefits over standard care.

Keep in mind

The study was designed around feasibility. Reported symptom changes were before-and-after observations, without a clear between-group treatment estimate in the abstract, so effectiveness remains uncertain.

THE NUMBERS, WITH CONTEXT

What researchers found

91%

Session attendance

During the 14-week video-group intervention; standard care was the trial comparator, but the abstract gives no comparative attendance estimate.

Hepatol Commun, 2025 · Original source ↓

Participation was encouraging

Participants reported favorable views of the video format, program content and group experience. Technical and behavioral problems were minor. However, collecting saliva samples at home was not feasible, showing that feasibility differed across study procedures.

Symptom signals need context

Some changes in the factors studied correlated with mental health and symptom improvements, but the abstract does not specify which factors. Changes in eating and exercise showed no consistent relationship with patient-reported outcomes.

CHECK THE ORIGINAL

The original publication

Group-based telehealth stress management-lifestyle interventions are feasible for patients with chronic liver disease.

Evon DM, Liu C, Rollason C et al.
Hepatol Commun · 2025

PubMed ID
41264908
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.